Cardiac amyloidosis medical therapy: Difference between revisions
Created page with "{{Cardiac amyloidosis}} {{CMG}}; '''Associate Editor:''' {{CZ}} ==Supportive measures== *Physical activity may continue as long as the patient can tolerate it. *Diet restri..." |
|||
| Line 3: | Line 3: | ||
==Supportive measures== | ==Supportive measures== | ||
Physical activity may continue as long as the patient can tolerate it. | |||
Diet restrictions vary with the extent of [[cardiomyopathy]] and [[heart failure]]. These may include [[salt]] and/or [[fluid]] restrictions. | |||
==Pharmacotherapy== | ==Pharmacotherapy== | ||
Revision as of 15:30, 12 February 2012
|
Cardiac amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac amyloidosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Cardiac amyloidosis medical therapy |
|
Risk calculators and risk factors for Cardiac amyloidosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor: Cafer Zorkun, M.D., Ph.D. [2]
Supportive measures
Physical activity may continue as long as the patient can tolerate it.
Diet restrictions vary with the extent of cardiomyopathy and heart failure. These may include salt and/or fluid restrictions.
Pharmacotherapy
Diuretics (water pills) may be given to remove excess fluid.
Digoxin may be used cautiously to improve heart control in patients with atrial fibrillation.
Daily weight measurement may be recommended. A weight gain of 3 or 4 pounds or more over 1 or 2 days can indicate excessive fluid accumulation.
Some people benefit from chemotherapy or prednisone.
Pacemaker
A pacemaker may be needed if the conduction system is involved.